Perfil
Eduard Enrico Holdener is currently the Chairman at NovImmune SA, Director at Cellerix SA, and Director at Swiss Cancer Foundation.
Previously, he served as an Independent Director at PAREXEL International Corp.
from 2015 to 2017, Independent Director at TiGenix NV, Director at HBM Healthcare Investments AG from 2008 to 2021, Non-Executive Director at Ipsen Bioinnovation Ltd., Head of Drug Development at Roche Holding AG from 1995 to 2007, and Chief Medical Officer at F.
Hoffmann-La Roche Ltd. in 2008.
Holdener holds a doctorate degree from the University of Basel and the University of Zurich.
Cargos activos de Eduard Enrico Holdener
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVIMMUNE SA | Presidente | 01/02/2008 |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Director/Miembro de la Junta | 01/01/2009 |
Swiss Cancer Foundation | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Eduard Enrico Holdener.
| Empresas | Cargo | Fin |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Director/Miembro de la Junta | 18/06/2021 |
| PAREXEL INTERNATIONAL CORPORATION | Director/Miembro de la Junta | 29/09/2017 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director Técnico/Científico/I+D | 01/02/2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/01/2007 |
| TIGENIX NV | Director/Miembro de la Junta | - |
Formación de Eduard Enrico Holdener.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
TiGenix NV
TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellerix SA
Cellerix SA Pharmaceuticals: GenericHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Novimmune SA
Novimmune SA BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Swiss Cancer Foundation | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
- Bolsa de valores
- Insiders
- Eduard Enrico Holdener
















